Colicin-like bacteriocins as novel therapeutic agents for the treatment of chronic biofilm-mediated infection. (Q54322861)

27 May 2018

title

Colicin-like bacteriocins as novel therapeutic agents for the treatment of chronic biofilm-mediated infection. (English)

1 reference

27 May 2018

1 reference

1 reference

27 May 2018

Laura McCaughey

0 references

Carla L Brown

1 reference

27 May 2018

Karen Smith

series ordinal

1 reference

27 May 2018

publication date

1 December 2012

1 reference

27 May 2018

Biochemical Society Transactions

published in

1 reference

27 May 2018

volume

1 reference

27 May 2018

issue

1 reference

27 May 2018

page(s)

1549-1552

1 reference

27 May 2018

The clinical impact of bacterial biofilms

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Bacterial Biofilms: An Emerging Link to Disease Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Mechanisms of biofilm resistance to antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Ferredoxin containing bacteriocins suggest a novel mechanism of iron uptake in Pectobacterium spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Immunity proteins: enzyme inhibitors that avoid the active site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

TonB induces conformational changes in surface-exposed loops of FhuA, outer membrane receptor of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Swimming against the tide: progress and challenges in our understanding of colicin translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

The pyocins of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

The soluble pyocins S2 and S4 from Pseudomonas aeruginosa bind to the same FpvAI receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Pyocin S2 (Sa) kills Pseudomonas aeruginosa strains via the FpvA type I ferripyoverdine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Crohn disease--associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Colicins prevent colonization of urinary catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Treatment of Staphylococcus aureus in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Activity of pyocin S2 against Pseudomonas aeruginosa biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Management of Crohn's disease in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Role of conventional therapies in the era of biological treatment in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

Small-Colony Variants of Pseudomonas aeruginosa in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120241

21 January 2018

Identifiers

DOI

10.1042/BST20120241

1 reference

27 May 2018

1 reference

27 May 2018